Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

August 1, 2023

Conditions
COVID19Cardiovascular Diseases
Interventions
DIAGNOSTIC_TEST

Non-invasive cardiac imaging

Cardiac MRI ± CT coronary angiography ± Cardiac PET/MRI (68Ga-DOTATATE or 18F-FDG)

Trial Locations (1)

CB2 0QQ

Cambridge Univeristy Hospitals NHS Foundation Trust, Cambridge

All Listed Sponsors
collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

British Heart Foundation

OTHER

collaborator

Wellcome Trust

OTHER

lead

University of Cambridge

OTHER

NCT04412369 - Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury | Biotech Hunter | Biotech Hunter